• <a fr-original-style="" href="https://www.bloomberg.com/news/articles/2021-12-13/pfizer-to-acquire-arena-in-deal-valued-at-6-7-billion?sref=4TAH79Na" rel="noopener noreferrer" style="color: rgb(9, 9, 9); text-decoration: none; background-color: transparent; outline: none; cursor: pointer; transition: color 0.3s ease 0s; touch-action: manipulation; user-select: auto; box-sizing: border-box;" target="_blank">Pfizer</a> announced that it would buy drug developer Arena Pharmaceuticals for $6.7 billion (€6bn) in cash, boosting the share price of Arena by nearly 84%.<ul fr-original-style="padding-inline-start: 20px;" style="padding-inline-start: 20px; margin-top: 0px; margin-bottom: 1em; list-style-position: inside; box-sizing: border-box;"><li fr-original-style="" style="box-sizing: border-box;">The treatment pipeline: The company last month acquired the immuno-oncology company Trillium Therapeutics for about $2.22 billion (€2bn) to expand its range of blood cancer treatments.</li></ul>

immuno-oncology ile ilgili hikayeler